[Effect of thymalin on the cyclic nucleotide system in the mouse spleen].
Gavrilenko. I S IS; Khavinson. V Kh VKh; Morozov. V G VG; Ivnitskiĭ. Iu Iu IuIu
Key Findings
- Thymalin (1000 µg per mouse, i.p.) produced two‑phase changes in spleen cAMP and cGMP levels
- cAMP phosphodiesterase activity was also altered in a two‑phase pattern
- The cAMP level changes appeared to be driven by the phosphodiesterase activity shifts
Practical Outcomes
- The results show thymalin can affect cyclic nucleotide signaling in mouse spleen tissue, but the study offers no clear guidance for human dosing or health benefits. For biohackers, it’s a mechanistic clue rather than an actionable protocol, so it has limited practical use at this stage.
Summary
A mouse study found that giving thymalin (a thymus extract) caused temporary ups and downs in two important cell signaling molecules, cAMP and cGMP, in the spleen, and also changed the enzyme that breaks down cAMP. The changes in cAMP levels seemed to follow the enzyme activity changes.
Abstract
The effect of the thymus preparation thymalin (1000 micrograms/mouse, i.p.) on the system of cyclic nucleotides in the spleen has been studied. The preparation produced two-phasic changes in the content of cAMP and cGMP, as well as in the activity of cAMP phosphodiesterase. The changes in the spleen cAMP content are consequent on those in the activity of phosphodiesterase.
Study Information
pubmed
1982